Corteva (CTVA) to Release Quarterly Earnings on Tuesday

Corteva (NYSE:CTVA) is anticipated to post its Q4 2025 results after the market closes on Tuesday, February 3rd. Analysts expect Corteva to post earnings of $0.22 per share and revenue of $4.2281 billion for the quarter. Parties are encouraged to explore the company’s upcoming Q4 2025 earning overview page for the latest details on the call scheduled for Wednesday, February 4, 2026 at 9:00 AM ET.

Corteva (NYSE:CTVA) last announced its quarterly earnings results on Tuesday, November 4th. The company reported ($0.23) earnings per share for the quarter, beating the consensus estimate of ($0.49) by $0.26. The business had revenue of $2.62 billion during the quarter, compared to analysts’ expectations of $2.47 billion. Corteva had a net margin of 9.19% and a return on equity of 9.37%. The firm’s revenue for the quarter was up 6.5% compared to the same quarter last year. During the same quarter in the prior year, the company posted ($0.49) EPS. On average, analysts expect Corteva to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.

Corteva Stock Performance

Corteva stock opened at $72.60 on Tuesday. The company has a current ratio of 1.58, a quick ratio of 1.07 and a debt-to-equity ratio of 0.07. The firm has a market cap of $49.06 billion, a P/E ratio of 31.03, a P/E/G ratio of 1.82 and a beta of 0.74. Corteva has a 1-year low of $53.40 and a 1-year high of $77.41. The firm has a 50-day moving average of $67.43 and a 200-day moving average of $68.33.

Corteva Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, December 15th. Investors of record on Monday, December 1st were given a dividend of $0.18 per share. The ex-dividend date was Monday, December 1st. This represents a $0.72 annualized dividend and a dividend yield of 1.0%. Corteva’s payout ratio is currently 30.77%.

Hedge Funds Weigh In On Corteva

Hedge funds have recently added to or reduced their stakes in the company. Sunbelt Securities Inc. boosted its stake in Corteva by 52.8% during the 3rd quarter. Sunbelt Securities Inc. now owns 923 shares of the company’s stock valued at $62,000 after purchasing an additional 319 shares during the last quarter. Coldstream Capital Management Inc. boosted its position in shares of Corteva by 6.3% during the third quarter. Coldstream Capital Management Inc. now owns 14,967 shares of the company’s stock valued at $1,012,000 after buying an additional 892 shares during the last quarter. Financial Engines Advisors L.L.C. bought a new stake in Corteva in the 3rd quarter worth about $203,000. Palisade Asset Management LLC purchased a new position in Corteva in the 3rd quarter worth about $67,000. Finally, NewEdge Advisors LLC lifted its stake in Corteva by 2.2% during the 3rd quarter. NewEdge Advisors LLC now owns 31,587 shares of the company’s stock valued at $2,136,000 after acquiring an additional 695 shares during the period. 81.54% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several brokerages have commented on CTVA. Citigroup raised their price objective on shares of Corteva from $70.00 to $74.00 and gave the stock a “neutral” rating in a report on Wednesday, January 21st. Deutsche Bank Aktiengesellschaft dropped their price target on Corteva from $90.00 to $85.00 and set a “buy” rating on the stock in a research report on Thursday, November 6th. Oppenheimer reiterated an “outperform” rating and issued a $76.00 price objective on shares of Corteva in a report on Friday, November 7th. Royal Bank Of Canada dropped their target price on shares of Corteva from $86.00 to $80.00 and set an “outperform” rating on the stock in a report on Friday, October 17th. Finally, Argus raised shares of Corteva to a “strong-buy” rating in a research report on Friday, January 16th. Two analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Corteva currently has a consensus rating of “Moderate Buy” and an average target price of $79.47.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.